Výsledky vyhledávání - "M. K. van der Kooij"

Akademický článek

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

Autor: T. M. L. Tong, M. K. van der Kooij, F. M. Speetjens, A. R. van Erkel, R. W. van der Meer, J. Lutjeboer, E. L. van Persijn van Meerten, C. H. Martini, R. W. M. Zoethout, F. G. J. Tijl, C. U. Blank, M. C. Burgmans, E. Kapiteijn

Publikováno v: Trials, Vol 23, Iss 1, Pp 1-13 (2022)

Abstract Background While immune checkpoint inhibition (ICI) has revolutionized the treatment of metastatic cutaneous melanoma, no standard treatments are available for patients with metastatic uveal melanoma (UM). Several locoregional therapies are

Externí odkaz: https://doaj.org/article/02b20954af9940f199b502ac5e14eeeb

Zobrazit plný text záznamu

Plný text ve formátu HTML

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands

Autor: Frank M. Speetjens, M. K. van der Kooij, Ellen Kapiteijn, Rutger H. T. Koornstra, J.W.B. de Groot, Geke A. P. Hospers, C. Bisschop, C. Blank, A. Joosse

Publikováno v: Acta Oncologica, 56, 1, pp. 101-103
Acta Oncologica, 56(1), 101-103
Acta Oncologica, 56, 101-103
ACTA ONCOLOGICA, 56(1), 101-103. Taylor & Francis Ltd

To the Editor,Uveal melanoma (UM) is a rare type of melanoma, with an incidence of 4.4 cases per million in Europe each year [1]. During recent years, different treatment approaches have been teste...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939d3df947f812b0ae415349e3530181
https://hdl.handle.net/1887/114279

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání